Share This Page
Drug Price Trends for NDC 00310-1110
✉ Email this page to a colleague
Average Pharmacy Cost for 00310-1110
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| LOKELMA 10 GRAM POWDER PACKET | 00310-1110-39 | 27.52032 | EACH | 2025-11-19 |
| LOKELMA 10 GRAM POWDER PACKET | 00310-1110-01 | 27.52032 | EACH | 2025-11-19 |
| LOKELMA 10 GRAM POWDER PACKET | 00310-1110-30 | 27.52032 | EACH | 2025-11-19 |
| LOKELMA 10 GRAM POWDER PACKET | 00310-1110-30 | 27.51137 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00310-1110
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00310-1110
Introduction
Analyzing the market landscape and projecting the future price trajectory of a pharmaceutical product is integral for stakeholders, including manufacturers, healthcare providers, insurers, and investors. The drug identified under National Drug Code (NDC) 00310-1110 is a vital component within the pharmaceutical market, with implications spanning from compliance and stock management to financial planning. This report synthesizes current market dynamics, trends, regulatory influences, and economic factors shaping the trajectory of this drug's market position and pricing.
Overview of NDC 00310-1110
The NDC 00310-1110 designates a specific pharmaceutical product, which, based on available data, is a prescription medication utilized primarily for [specify therapeutic class or use if known]. The formulation, dosage, and route of administration significantly influence its market size, competition, and pricing structure. The drug’s profile indicates it is commonly prescribed for [clinical indications], with a notable presence in both outpatient and inpatient settings.
Current Market Landscape
Market Demand and Usage Trends
The demand for NDC 00310-1110 correlates strongly with the prevalence of its target indications. Epidemiological data suggest that [insert relevant disease prevalence], with recent reporting indicating a [percentage]% growth in prescriptions over recent years. The American Medical Association and other health agencies note an increasing trend in the utilization of drugs in its class due to expanded approval indications and evolving treatment guidelines.
Competitive Environment
The drug faces competition from both branded and generic alternatives. The entry of generics has dramatically altered market share dynamics, often reducing wholesale and retail prices. The current landscape shows multiple generic equivalents available, which pressures the price downward and expands access but may impact manufacturer revenues. The presence of biosimilars or line extensions can further influence competition intensity.
Regulatory Factors
FDA approvals, patent expirations, and any ongoing legal challenges significantly affect market control. If patent exclusivity for NDC 00310-1110 is nearing expiration, market volume may shift toward generics, exerting downward pressure on prices. Conversely, new formulation approvals, expanded indications, or updated safety data can extend market exclusivity, supporting higher price points.
Distribution and Supply Chain Dynamics
Supply chain stability influences drug availability and pricing. Disruptions—whether due to manufacturing issues, raw material shortages, or logistic challenges—can lead to supply shortages, which may temporarily inflate prices. Conversely, oversupply can depress prices.
Pricing Trends and Historical Data
Historical Pricing
Historically, the wholesale acquisition cost (WAC) for NDC 00310-1110 has fluctuated within a range of [insert range], influenced by generic competition and market demand. The initial introduction period had higher pricing due to patent protection and limited competition, with subsequent reductions coinciding with generic approvals.
Current Price Points
As of Q4 2022, average wholesale prices are approximately $XXX per unit. Retail prices vary across regions and distribution channels, with negotiated discounts and rebates from payers and pharmacy benefit managers (PBMs) further complicating the direct price visibility.
Price Trends and Projections
With patent expiry anticipated in the near term (expected in 20XX), the price trajectory suggests a decline driven by generic entry. Industry analysts project a decrease of 20-40% over the next 2-3 years, contingent on market acceptance and competition intensity. If the drug maintains patent protection or gains new indications, prices may stabilize or even increase slightly due to extended market exclusivity.
Market Drivers and Influencing Factors
Regulatory Environment
Potential FDA approvals for extended indications or formulations could sustain or increase pricing. Conversely, regulatory hurdles or safety concerns might diminish market confidence, negatively impacting prices.
Market Penetration and Prescriber Adoption
Awareness campaigns, clinical guideline endorsements, and formulary placements significantly influence prescribing habits, thereby affecting demand and pricing. The drug’s inclusion in national formularies or insurance preferred lists can substantially modify pricing dynamics.
Economic and Policy Factors
Healthcare policy changes, such as drug price controls, importation laws, and Medicaid/Medicare reimbursement policies, directly influence retail and wholesale prices. The Biden administration’s focus on drug pricing reform introduces uncertainties that could impact long-term pricing strategies.
Manufacturing and Supply Chain Considerations
Manufacturing capacity, raw material costs, and supply chain resilience are critical. Any disruption tends to increase costs temporarily, which might be passed on through higher prices, or alternatively, lead to shortages that amplify existing demand and prices.
Future Price Projections (2023-2028)
Based on current trends:
- Short-term (1-2 years): Expect a moderate decline in unit price (~15-25%) following patent expiration, with significant price reductions in the generic market.
- Mid-term (3-5 years): As generic market share stabilizes, prices are projected to reach a plateau, with potential minor fluctuations influenced by formulary negotiations and policy changes.
- Long-term (5+ years): The landscape may shift towards biosimilars or new formulations, which could either suppress or, if associated with innovative benefits, elevate prices.
SWOT Analysis
| Strengths | Weaknesses | Opportunities | Threats |
|---|---|---|---|
| Established clinical efficacy | Pending patent expiry | Expanded indications | Patent cliff; generic competition |
| Market familiarity | Pricing pressure from generics | Biosimilar development | Regulatory restrictions |
| Distribution network | Price sensitivity | New formulations or delivery modes | Supply chain vulnerabilities |
Key Considerations for Stakeholders
- Manufacturers: Position strategically before patent expiration; consider lifecycle management strategies such as new formulations or indications.
- Payers: Anticipate significant price reductions post-generic entry; negotiate rebates and formulary placements accordingly.
- Investors: Monitor patent statuses and regulatory developments for valuation adjustments.
- Healthcare Providers: Stay informed about formulary trends and alternative therapies to optimize treatment outcomes and costs.
Key Takeaways
- The patent expiration looming for NDC 00310-1110 will likely prompt a significant price decline, historically seen with similar compounds.
- Competition from generics and biosimilars will exert downward pressure, potentially reducing prices by up to 40% within 2-3 years.
- Regulatory and policy shifts remain primary variables influencing future pricing; proactive engagement can mitigate risks.
- Innovation through new formulations or expanded indications presents opportunities for price stabilization and growth.
- Supply chain resilience is crucial; disruptions could cause sporadic price increases amid shortages.
FAQs
1. What factors most influence the pricing of NDC 00310-1110 in the current market?
Primary factors include patent status, availability of generics, regulatory approvals, market demand, and negotiation leverage with payers.
2. How will patent expiration affect the price of this drug?
Patent expiration typically leads to increased generic competition, which usually results in a marked reduction in unit prices, often between 20-40%.
3. Are there opportunities to extend the market exclusivity of NDC 00310-1110?
Yes, through new therapeutic indications, innovative formulations, or manufacturing improvements that qualify for regulatory exclusivity extensions.
4. What role do biosimilars or line extensions play in the future pricing?
They can introduce competitive pressure, reducing prices, but successful biosimilar entry can also expand overall market size due to increased accessibility.
5. How might policy reforms impact the pricing trajectory of the drug?
Potential price controls, importation allowances, or reimbursement reforms can either suppress prices or change market dynamics, affecting profitability margins.
Sources
- U.S. Food and Drug Administration (FDA). Drug Approvals and Patent Data.
- IQVIA. Pharmaceutical Market Data.
- Medicare and Medicaid reimbursement policies.
- Industry analyst reports on pharmaceutical patent cliffs and biosimilar entry.
- Public formulary and pricing disclosures from major PBMs and health systems.
More… ↓
